Harvard Thinking: Who should take GLP-1s?
From Harvard University · · 27 min

The player loads from YouTube only when you click. It uses YouTube's privacy-enhanced mode.
If the video does not play, the owner may have turned off embedding. Watch it on YouTube instead.
Not rated yet
Description
GLP-1 usage has surged as a weight loss management drug. But given how new they are to the market, medical professionals are only now starting to figure out who should – and should not – be using them. In this episode, host Samantha Laine Perfas talks with obesity specialist Caroline Apovian, evolutionary biologist Daniel Lieberman, and obesity medicine physician scientist Fatima Cody Stanford about why we should be excited – and cautious – about the potential of GLP-1s.